Why does Ozempic change your bowels at all?
It’s not a side effect that snuck in — it’s connected to the exact mechanism these drugs are built on. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work partly by substantially slowing down how fast your stomach empties, which is a big part of why you feel full longer [1][2]. That same slowdown extends into your small intestine and colon — stool spends more time in transit, and your colon gets more time to pull water out of it, which is the direct mechanical reason for constipation later in treatment. On top of that, most people are simply eating and drinking less overall, which means less bulk moving through the gut to trigger the normal urge to go.
Two opposite clusters — “slow gut” vs. “fast gut”
GLP-1 GI side effects aren’t one story, they’re two, and they can hit the same person at different points in treatment — both cluster around injection day and dose-increase days:
- “Slow gut” — nausea, sulfur or “egg” burps, and constipation. This is the cluster people online self-diagnose from the smell alone: distinctive sulfur- or rotten-egg-smelling burps are common enough on GLP-1s that strangers guess “you’re probably on Wegovy/Ozempic” from that detail alone. It’s tied to the same slowed-stomach-emptying mechanism as the nausea, and it’s also the cluster people describe as the actual reason they stall at a low dose or quit the medication altogether — constipation, not diarrhea, is more often the dose-limiting complaint long-term [1].
- “Fast gut” — urgent, loose stools. The other side of the same coin: some people get explosive, urgent diarrhea instead, especially right after starting or right after a dose bump, before things settle.
Both clusters can happen to the same person at different times — it’s not “you’re a diarrhea person or a constipation person,” it’s that both failure modes come from the same underlying slowdown, and which one shows up (or when) varies. In the large trial behind Ozempic and Wegovy, nausea affected about 44% of people on the drug (versus 17% on placebo), diarrhea about 32% (versus 16%), and constipation about 23% (versus 10%) [1]. Tirzepatide trials show a similar early-heavy pattern, concentrated around dose escalation steps [2].
The short version: early on, and again after each dose increase, loose stool, nausea, and sulfur burps are the more common complaints. Longer-term, constipation tends to be the one that sticks around and the one most likely to make someone stop treatment, because it comes from the drug’s ongoing effect rather than your body still adjusting [1].
Does the GI upset get better over time?
Usually, yes, for the nausea and early diarrhea — most people see those ease within weeks as the body adapts to a given dose. Constipation is less likely to “tolerate out” the same way, since it flows from the drug’s core slowed-motility effect rather than an adjustment period [1][2].
What actually helps?
For the “slow gut” cluster: fiber and fluids, paired with patience through each dose-stage adjustment, are the practical first-line approach for the constipation — the same tools that help constipation generally (see Constipation Remedies That Actually Work for the graded, evidence-ranked list). Because these drugs also reduce appetite and total food/fluid volume, deliberately keeping fiber and water intake up — rather than assuming you’ll “naturally” get enough since you’re eating less — is worth being intentional about. For the nausea and sulfur burps specifically, smaller lower-fat meals, eating slowly and stopping before you feel full, and avoiding high-fat or high-sulfur trigger foods (eggs, red meat, cruciferous vegetables) around dose days are the commonly reported coping strategies — real first steps, not a substitute for calling your prescriber if it doesn’t ease up.
For the “fast gut” cluster: the same general loose-stool approach as any diarrhea — smaller meals, staying ahead of fluids and electrolytes, and easing back on high-fat or high-fiber foods until it settles — plus the same dose-stage patience, since this cluster typically eases within a couple of weeks after starting or after a dose increase [1][2].
When to actually worry
Routine GI adjustment is common enough on these drugs that it’s genuinely expected, not a sign something’s wrong. A smaller number of signals point toward something that needs your prescriber, not just home management:
- Persistent, severe vomiting that isn’t settling — worth a call, since dehydration and electrolyte issues can follow [3].
- Severe or worsening abdominal pain, especially if it’s new and doesn’t fit the usual post-dose nausea pattern — pharmacovigilance data on semaglutide has flagged rarer but more serious signals worth ruling out, including pancreatitis and significantly delayed gastric emptying (gastroparesis) [3].
- Constipation that isn’t responding to fiber, fluids, and time — worth discussing dose or additional treatment with your prescriber rather than pushing through indefinitely.
If you’re a few weeks into a new dose and dealing with the “normal” version of this — some nausea, some looser stool, easing up gradually — that matches what most people on these medications experience, and isn’t something to panic-search over. If constipation is the persistent issue, the fiber/fluid approach above is the practical next step, not a wait-and-see.
Not sure if what you’re experiencing is typical for your dose stage? The PoopRx wizard walks through it in a couple minutes, free, no login.